We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLLI
1176
DELISTED
Globalink Investment Inc. Common Stock
GLLI
$4.93M 0.01%
483,804
NVEI
1177
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$4.93M 0.01%
194,081
-119,119
-38% -$3.37M
PI icon
1178
Impinj
PI
$3.97B
$4.93M 0.01%
45,153
+38,952
+628% +$4.1M
SCMA
1179
DELISTED
Seaport Calibre Materials Acquisition Corp. Class A Common Stock
SCMA
$4.93M 0.01%
479,878
AR icon
1180
Antero Resources
AR
$10.5B
$4.91M 0.01%
158,341
-464,843
-75% -$16.1M
DXLG icon
1181
Destination XL Group
DXLG
$34.3M
$4.91M 0.01%
726,926
+42,965
+6% +$275K
IGMS
1182
DELISTED
IGM Biosciences
IGMS
$4.89M 0.01%
287,428
+40,739
+17% +$815K
PFE icon
1183
CALL
Pfizer
PFE
$141B
$4.88M 0.01%
95,300
-259,900
-73% -$12.5M
AERTW
1184
CALL
Aeries Technology Warrant
AERTW
$4.88M 0.01%
475,896
JUGG
1185
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
$4.87M 0.01%
484,638
ALRM icon
1186
Alarm.com
ALRM
$2.65B
$4.86M 0.01%
98,196
+90,765
+1,221% +$5M
PCRX icon
1187
Pacira BioSciences
PCRX
$1.04B
$4.84M 0.01%
125,357
+82,396
+192% +$4.01M
HCA icon
1188
HCA Healthcare
HCA
$86.4B
$4.83M 0.01%
20,115
-176,076
-90% -$39.4M
ONYX
1189
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
$4.79M 0.01%
464,701
-758,836
-62% -$7.77M
PGSS.WS
1190
CALL
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$4.76M 0.01%
463,240
SNRHW
1191
CALL
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$4.76M 0.01%
487,597
GMFI
1192
DELISTED
Aetherium Acquisition Corp
GMFI
$4.76M 0.01%
467,225
IIIV icon
1193
i3 Verticals
IIIV
$404M
$4.76M 0.01%
195,406
-1,830
-0.9% -$41.3K
ENTF
1194
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares
ENTF
$4.75M 0.01%
461,696
UA icon
1195
Under Armour Class C
UA
$2.95B
$4.75M 0.01%
532,135
+511,410
+2,468% +$3.89M
CITE
1196
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$4.74M 0.01%
457,428
KOF icon
1197
Coca-Cola Femsa
KOF
$22.9B
$4.74M 0.01%
69,866
+65,899
+1,661% +$4.29M
HLMN icon
1198
Hillman Solutions
HLMN
$1.58B
$4.74M 0.01%
657,299
-855,285
-57% -$6.43M
PXD
1199
DELISTED
Pioneer Natural Resource Co.
PXD
$4.73M 0.01%
20,697
-13,638
-40% -$3.32M
KAIR
1200
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$4.72M 0.01%
468,971
-881,280
-65% -$8.84M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.